Evidence map›Paper›PMID 38341498›Full record

ArticleBone marrow transplantation2024

Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation.

Ryusuke Yamamoto, Nobuhiro Hiramoto, Ayumi Fujimoto, Hirohito Yamazaki, Takehiko Mori, Naoyuki Uchida, Noriko Doki, Jun Kato, Masashi Nishikubo, Shinichi Kako and 11 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Ryusuke YamamotoDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
Nobuhiro HiramotoDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan. kvlqt1789@gmail.com.ORCID 0000-0002-0472-6680
Ayumi FujimotoDepartment of Hematology, Shimane University Hospital, Izumo, Japan.ORCID 0000-0001-5406-9300
Hirohito YamazakiDivision of Transfusion Medicine, Kanazawa University Hospital, Kanazawa, Japan.ORCID 0000-0003-3018-2098
Takehiko MoriDepartment of Hematology, Tokyo Medical and Dental University, Tokyo, Japan.ORCID 0000-0002-8176-4760
Naoyuki UchidaDepartment of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan.ORCID 0000-0001-5952-5926
Noriko DokiHematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.ORCID 0000-0002-8661-3179
Jun KatoDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.ORCID 0000-0003-1869-5480
Masashi NishikuboDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.ORCID 0000-0002-6183-8910
Shinichi KakoDivision of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.ORCID 0000-0002-2635-3395
Tetsuya NishidaDepartment of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.
Shuichi OtaDepartment of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.ORCID 0000-0002-3631-244X
Makoto OnizukaDepartment of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.ORCID 0000-0003-3864-0823
Tetsuya EtoDepartment of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
Koichi OnoderaDepartment of Hematology, Tohoku University Hospital, Sendai, Japan.
Kazuhiro IkegameDepartment of Hematology, Hyogo Medical University Hospital, Hyogo, Japan.ORCID 0000-0002-5421-7470
Ken-Ichi MatsuokaDepartment of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.ORCID 0000-0001-7955-8266
Yoshinobu KandaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.ORCID 0000-0002-4866-9307
Takahiro FukudaDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.ORCID 0000-0003-4404-2870
Yasushi OnishiDepartment of Hematology, Tohoku University Hospital, Sendai, Japan.ORCID 0000-0003-0032-6994

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anemia, AplasticAntilymphocyte SerumHematopoietic Stem Cell TransplantationLymphoproliferative DisordersAdolescentAdultAgedAllograftsChildFemaleHumansMaleMiddle AgedRetrospective StudiesRisk AssessmentTransplantation, HomologousAntilymphocyte Serum

Identifiers

PMID38341498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.